Tag: medical

Researchers in the United Kingdom are currently recruiting volunteers for a study designed to explore the effects of cannabis on the human brain. Subjects selected for the full study will be paid for their participation in the research, which is being undertaken as part of King’s College London’s Cannabis & Me project.

The researchers conducting the study have said that the research is “paramount” to understanding the science behind cannabis, which they say is used daily by approximately 200 million people worldwide and is subject to legalization efforts in countries around the globe. Dr. Marta Di Forti, a leading cannabis and psychosis researcher and the leader of the new study, noted that “Cannabis is consumed daily by many recreationally but also for medicinal reasons.”

“But in the UK, the prescription of medicinal cannabis remains rare,” Di Forti added, as quoted by the Daily Mail. “Our study aims to provide

The Minnesota Department of Health announced on Wednesday that the agency will add irritable bowel syndrome and obsessive-compulsive disorder to the list of qualifying medical conditions for participation in the state’s medical cannabis program. Under state law, the addition of the new qualifying conditions will become effective beginning on August 1, 2023, according to state officials.

“We are adding the new qualifying conditions to allow patients more therapy options for conditions that can be debilitating,” Minnesota Commissioner of Health Jan Malcolm said in a statement from the health department.

Irritable bowel syndrome (IBS) is a disorder characterized by abdominal pain or discomfort, as well as irregular bowel movements that can result in diarrhea, constipation, both diarrhea and constipation, or bloating. Obsessive-compulsive disorder (OCD) is characterized by recurring, intrusive thoughts that often cause significant emotional distress and anxiety in those living with the disorder. This can lead to repetitive actions or

A Montana-based company called Gaize has developed a device which can scan the user’s eye and utilize crazy futuristic robot intelligence to detect THC impairment.

According to the company’s founder, Ken Fichtler, American law enforcement agencies have already agreed to use the technology, though he could not specify which ones.

“I’ll preface all of this by saying I am pro cannabis. I’m pro cannabis legalization. I’m doing this because I see a distinct need at the federal level to have some product to detect impairment so we can keep roads safe,” Fichtler said.

The device is akin to a virtual reality headset of sorts that a police officer would hypothetically place on the head of a driver suspected of reefer smoking. It shrouds the suspect in darkness for a few moments before shining a bright light to electronically scan the movement of the suspect’s eyeballs.

“The eyes are the window

Certain low-income senior citizens in Pennsylvania will receive financial assistance for their medical cannabis treatment thanks to a newly launched pilot program in the state.

According to Capitol Wire, the state’s Department of Health launched the program “to offer $50 a month in financial assistance to help almost 1,400 senior citizens afford the cost of medical marijuana.”

“The payments are the first step toward establishing a third phase for the financial assistance program authorized to help low-income medical marijuana patients afford the drug. Because insurance companies don’t include medical marijuana in their prescription drug coverage, medical marijuana patients are left to pony up the full cost of medical marijuana when they visit the state’s dispensaries,” Capitol Wire reported.

Even so, that’s a small portion of the pool of patients who are potentially eligible for the discount, with Capitol Wire reporting that the state “doesn’t have sufficient funding to provide meaningful

Enthea, the healthcare provider that specializes in psychedelic therapy, announced on Tuesday that it will “launch its services into 40 markets across the U.S. next year as well as grow Enthea’s customer base and provider network to further its mission of providing affordability and access to safe and effective psychedelic-assisted therapies for all who can benefit.”

The ambitious launch is the byproduct of a “successful $2M seed round raise, led by Tabula Rasa Ventures, the first psychedelic accelerator for early-stage startups,” the company said in the announcement.

Enthea says that the driving force behind the new endeavor is to improve access to potentially breakthrough psychedelic treatment amid an ever-spiraling mental health crisis in the United States.

The company asserts that it is “helping in this mental health crisis by bringing employer funding for these new treatments,” saying that “traditional health insurers are years away from adding this coverage, the cost